differentiation syndrome

From Aaushi
Jump to navigation Jump to search

Etiology

Clinical manifestations

Complications

  • can be fatal if not treated

Management

More general terms

References

  1. FDA News Release. August 1, 2017 FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm569421.htm